Helicos BioSciences Corp (HLCSQ1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
ONE KENDALL SQUARE, BUILDING 200, CAMBRIDGE, MA 02139
617-649-0540

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

View SEC Filings from HLCSQ1 instead.

View recent insider trading info

Funds Holding HLCSQ1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HLCSQ1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TRIFUNOVICH IVAN CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
848,950 2011-10-14 0

MOORE JEFFREY R. SVP, CFO & TREASURER

  • Officer
77,626 2011-07-01 0

LOWY RONALD A PRESIDENT & CEO

  • Officer
  • Director
695,847 2010-10-01 0

LEVINE MARC S SVP, PRODUCT DEVELOPMENT

  • Officer
68,164 2010-07-01 0

MELAS KYRIAZI THEO

  • Director
45,716 2010-04-15 0

ALLISON ELISABETH

  • Director
39,273 2010-04-15 0

EFCAVITCH J WILLIAM SVP & CHIEF TECHNOLOGY OFFICER

  • Officer
151,087 2010-03-31 0

LOMBARDI STEPHEN J PRESIDENT

  • Officer
  • Director
251,143 2010-01-04 0

HIGGINS ROBERT F

  • Director
  • 10% Owner
12,012,213 2009-09-18 0

FLAGSHIP VENTURES FUND 2004 L P

FLAGSHIP VENTURES GENERAL PARTNER LLC

FLAGSHIP VENTURES MANAGEMENT, INC.

KANIA EDWIN M JR

NEWCOGEN ELAN LLC

NEWCOGEN EQUITY INVESTORS LLC

NEWCOGEN GROUP LLC

NEWCOGEN GROUP, INC.

NEWCOGEN PE LLC

ST NEWCOGEN LLC

  • Director
  • 10% Owner
12,353,461 2009-09-18 0

ATLAS VENTURE FUND V LP

ATLAS VENTURE FUND VI GMBH & CO KG

ATLAS VENTURE FUND VI LP

ATLAS VENTURE ASSOCIATES V LP

ATLAS VENTURE ASSOCIATES VI, L.P.

ATLAS VENTURE ENTREPRENEURS FUND V LP

ATLAS VENTURE ENTREPRENEURS FUND VI LP

  • Director
  • 10% Owner
12,012,208 2009-09-18 0

HIGHLAND CAPITAL PARTNERS VI LP

  • Director
  • 10% Owner
7,518,291 2009-09-18 0

VERSANT VENTURE CAPITAL II, LP

SAMUELS CAMILLE D

LINK WILLIAM J PHD

ROBERTSON REBECCA B

JAFFE ROSS A MD

BOLZON BRADLEY J PHD

WARDEN CHARLES M

  • 10% Owner
15,902,588 2009-09-18 0

COLELLA SAMUEL D

LUBASH BARBARA N

MILDER DONALD B

  • 10% Owner
15,902,588 2009-09-18 0

AFEYAN NOUBAR

  • Director
  • 10% Owner
12,353,461 2009-09-18 0

AFEYAN NOUBAR

NEWCOGEN LONG REIGN HOLDING LLC

  • Director
  • 10% Owner
12,353,461 2009-09-18 0

HIGHLAND MANAGEMENT PARTNERS VI L P

  • Director
  • 10% Owner
11,639,837 2009-09-18 0

ATWOOD BRIAN G

  • Director
  • 10% Owner
15,902,588 2009-09-18 0

BARRETT PETER

  • Director
  • 10% Owner
12,012,208 2009-09-18 0

HEF VI, LIMITED PARTNERSHIP

  • Director
372,376 2009-09-18 0

FLAGSHIP VENTURES FUND 2004 L P

FLAGSHIP VENTURES GENERAL PARTNER LLC

FLAGSHIP VENTURES MANAGEMENT, INC.

NEWCOGEN GROUP, INC.

AGTC PARTNERS, L.P.

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

KANIA EDWIN M JR

  • 10% Owner
0 2009-08-06 0

HALL STEPHEN P SVP, CFO AND TREASURER

  • Officer
50,000 2009-01-28 0

AFEYAN NOUBAR

KANIA EDWIN M JR

NEWCOGEN ELAN LLC

NEWCOGEN EQUITY INVESTORS LLC

NEWCOGEN GROUP LLC

NEWCOGEN GROUP, INC.

NEWCOGEN PE LLC

ST NEWCOGEN LLC

  • Director
  • 10% Owner
17,122,127 2008-12-23 0

AGTC ADVISORS FUND LP

AGTC PARTNERS, L.P.

APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

FLAGSHIP VENTURES FUND 2004 L P

FLAGSHIP VENTURES GENERAL PARTNER LLC

FLAGSHIP VENTURES MANAGEMENT, INC.

  • Director
  • 10% Owner
17,122,127 2008-12-23 0

AFEYAN NOUBAR

KANIA EDWIN M JR

NEWCOGEN ELAN LLC

NEWCOGEN EQUITY INVESTORS LLC

NEWCOGEN GROUP LLC

NEWCOGEN GROUP, INC.

NEWCOGEN LONG REIGN HOLDING LLC

NEWCOGEN PE LLC

ST NEWCOGEN LLC

  • Director
  • 10% Owner
120,123 2007-05-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments